US Stock MarketDetailed Quotes

CRIS Curis

Watchlist
  • 1.890
  • -0.210-10.00%
Close May 9 16:00 ET
  • 1.890
  • 0.0000.00%
Post 20:01 ET
19.77MMarket Cap-0.31P/E (TTM)

About Curis Company

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Company Profile

SymbolCRIS
Company NameCuris
Listing DateAug 1, 2000
Founded2000
CEOMr. James E. Dentzer
MarketNASDAQ
Employees34
Fiscal Year Ends12-31
AddressBuilding C,128 Spring Street,Suite 500
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-617-503-6500
Websitehttp://www.curis.com

Company Executives

  • Name
  • Position
  • Salary
  • James E. Dentzer
  • Director, President and Chief Executive Officer
  • 1.97M
  • Diantha Duvall
  • Chief Financial Officer and Principal Accounting Officer
  • 1.07M
  • Jonathan B. Zung, PhD
  • Chief Development Officer
  • 1.10M
  • Martyn D. Greenacre
  • Chairman of the Board
  • 144.22K
  • Dr. Marc Rubin,M.D.
  • Independent Director
  • 109.22K
  • Dr. Kenneth I. Kaitin,PhD
  • Independent Director
  • 111.72K
  • Dr. John A. Hohneker, M.D.
  • Independent Director
  • 91.72K
  • Dr. Anne E. Borgman, M.D.
  • Independent Director
  • 89.22K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Collegium Pharmaceutical
COLL
28.890
Cars.com
CARS
10.430
New Fortress Energy
NFE
6.320
4
Precision Drilling
PDS
42.220
5
Lantheus
LNTH
81.740
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.